Hong Kong Stocks Closed Lower on September 3, Hang Seng Index Down 0.39% as Tech Stocks Dragged the Market
nashnova research
The Hang Seng Index fell 0.39% to 25,213 on Sept 3 as internet stocks slid in the afternoon session; but metals, shipping, and biotech bucked the trend, leaving the market sharply split by sector.
Why did tech stocks become the biggest drag today?
Alibaba fell over 2% and Tencent dropped more than 1%, pulling the Hang Seng Tech Index down 1.08%.
This means → tech's negative contribution to the index far outweighed every other sector; the morning rally reversed once internet names accelerated lower after lunch.
Trip.com fell 5.41%, alone dragging the HSI down 7.81 points.
Morgan Stanley cut Trip.com's 2026–2028 revenue forecasts by 1%–3% and EPS estimates by 2%–7%, citing macro headwinds, extreme weather, and geopolitical risks weighing on travel demand.
Why did metals and shipping rally against the tide?
U.S. August ADP private payrolls rose just 38,000 — well below the 47,000 expected. In plain terms = a number that weak made markets price in lower odds of a Fed rate hike in September, which is good for gold.
Gold stocks surged: Tongguan Gold +9.2%, Lingbao Gold +5.75%, Chifeng Gold +5.38%.
Shipping stocks also stood out — COSCO Shipping Energy +6.49%, Pacific Basin +5.02%. The Baltic Dry Index (BDI — the benchmark for global dry-bulk shipping rates) hit its highest since December 2023.
This reflects a double catalyst: the U.S. military striking two Iranian government-owned tankers pushed up oil-shipping risk premiums + El Niño risks and the approaching dry-bulk peak season lifted freight rates.
What sparked the biotech rally?
Hutchmed surged 14.32% to HK$21.88. The company signed a licensing deal with GSK for a novel cancer therapy — US$110 million upfront, up to US$1.295 billion in development and commercialization milestones, plus tiered royalties on net sales.
In plain terms = one deal locked in certain cash flow plus future sales sharing, and the market priced the upside in immediately.
Blue-chip pharma joined in: Sino Biopharmaceutical +6.27% — its subsidiary Chia Tai Tianqing won U.S. FDA IND clearance for an ADC drug (ADC — an antibody-drug conjugate that delivers chemotherapy directly to cancer cells); CSPC Pharma +4.8%.
Where is the property-sector recovery signal coming from?
Yuexiu Property +5.15%, China Resources Land +3.46%, China Jinmao +3.45%.
August secondary-home data from key cities flashed recovery signals: Beijing posted six consecutive months of year-on-year growth, Shanghai hit a five-year high for the period, and Shenzhen's actual signings jumped 12% month-on-month.
This means → transaction volumes in tier-one cities are steadily improving, giving the property-stock rebound fundamental support beyond pure sentiment.
Shein is joining the Hang Seng Composite — so why did it hit a new low?
Shein (00625) fell 8.7% to HK$42, a fresh post-listing low.
Hang Seng Indexes announced Shein will be added to the Hang Seng Composite Index after the close on Sept 14, effective Sept 15 — but the news failed to lift the stock.
This reflects fundamental concerns outweighing the passive-fund inflow that index inclusion typically brings.
What is the outlook from here?
Zheshang International sees the HSI still in a left-side adjustment channel on weekly and monthly timeframes, with near-term profit-taking pressure; their medium-term stance is neutral to cautious.
On sector allocation, they favor renewables, innovative pharma, and AI tech — areas benefiting from policy tailwinds.
In plain terms = the broad market hasn't exited its correction, but structural opportunities sit in policy-supported sectors — whether internet stocks can stabilize is the key signal for any broader recovery.
市场有风险，内容仅供研究参考，不构成投资建议。